Quantcast

Latest Cancer Research Stories

2014-02-12 23:25:49

Data from 2,000 cancer genomes to be jointly analyzed using uniform algorithms. Los Gatos, CA (PRWEB) February 12, 2014 Annai Systems Inc., a provider of genomic data management solutions, today announced that it has partnered with the Ontario Institute for Cancer Research (OICR) and the International Cancer Genome Consortium (ICGC) to provide its Annai GNOS™ data management software in support of six data centers around the world that will house a large data set for the Pan Cancer...

2014-02-11 16:25:49

Partnership to Raise Money for Research Grants Exploring the Impact of Healthy Living on Cancer & Cancer Related Diseases OWINGS MILLS, Md., Feb. 11, 2014 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs announced today its partnership with The V Foundation for Cancer Research, one of the nation's leading cancer research funding organizations. As part of this...

Children In The EU Denied Cancer Treatments Due To Regulations
2014-02-11 14:45:11

Lee Rannals for redOrbit.com - Your Universe Online European Union (EU) regulations are causing children with cancer to go without treatments, according to the Institute of Cancer Research (ICR). Leading cancer experts said that EU rules are causing some children with cancer to be denied potentially life-saving drugs because the guidelines only allow companies to trial some drugs only in adults. The experts believe that changes to these rules could allow children access to high...

2014-02-10 12:26:14

GOSSELIES, Belgium, February 10, 2014 /PRNewswire/ -- iTeos Therapeutics SA today announced the filing of the Company's first patent applications protecting proprietary inhibitors of the intracellular enzyme TDO2, which is expressed at high levels in specific cancers. iTeos Therapeutics has collaborated with Ludwig Cancer Research over the last year to identify small molecule inhibitors of the enzyme that display nanomolar potency, good selectivity, favorable pharmacokinetics...

2014-02-05 23:25:30

Moving the Needle in Brain Tumor Survivorship through Genomic Sequencing Seattle, WA (PRWEB) February 05, 2014 On January 22nd, 2014 the Chris Elliott Fund (CEF) and Foundation Medicine co-hosted a dinner in Seattle to share some of the latest developments in genomic profiling and the implications for brain tumor patients everywhere. The evening brought together a number of people from the Seattle Metro area: including patients, advocates, scientists, and physicians from Swedish Medical...

Protein Study Opens A New Avenue For Cancer Researchers
2014-02-04 13:09:26

Brigham Young University One of the hopes for victory against cancer hinges on naturally-occurring proteins whose job is to make their host cell die. Since their natural role is to stop unhealthy cell proliferation, the idea is that one or more of these proteins could be harnessed to stop the growth of tumors. Brigham Young University scientists recently stumbled onto one potential tumor suppressor with an especially ominous name: Programmed Cell Death Protein 5 (aka PDCD5). What...

2014-02-04 08:33:12

WESTLAKE, Ohio, Feb. 4, 2014 /PRNewswire/ -- GenomOncology today announced that the University of Pittsburgh has selected GenomOncology's GenomAnalytics(TM) platform and services to explore and mine the breadth of data that exists in The Cancer Genome Atlas (TCGA). (Photo: http://photos.prnewswire.com/prnh/20140204/CL58248LOGO) Cancer is a complex disease of the genome with each tumor having its own set of genetic anomalies. Increased understanding of the genetic changes in cancer...

2014-02-03 12:29:37

Co-inventors of ATM technology joining company as General Manager of the ATM Program, Scientific Advisory Panel member, respectively SYDNEY, Feb. 3, 2014 /PRNewswire/ -- Novogen Limited (ASX: NRT; NASDAQ: NVGN), an oncology drug development company, today announced the appointments of Justine Stehn, PhD and Professor Peter Gunning, PhD to roles within the Company. Dr. Stehn and Professor Gunning are the co-inventors of the anti-tropomyosin (ATM) drug technology platform that Novogen...

2014-02-03 12:29:02

MIAMI, Feb. 3, 2014 /PRNewswire/ -- Sunday afternoon, April 6(th) 2014, "Rockin' For The Cure" is hosting a Walk-a-thon ("Walkin' For The Cure") at Tropical Park in Miami, Florida to help raise money for the new Cancer Research and Treatment Center being built by the Baptist Health Foundation in South Florida. (Photo: http://photos.prnewswire.com/prnh/20140203/CL57227) On Wednesday, January 29, 2014, the Baptist Health Foundation announced plans to build the new $400 million...

2014-01-30 23:22:28

This report from BCC Research focuses on circulating tumor cell testing and monitoring methods, and includes an overview on cancer, diagnostic strategies, and treatment technologies. Important trends in the field of cancer research and development are reviewed and sales forecasts by treatment and screening categories are provided from 2013 through 2018. Wellesley, MA (PRWEB) January 30, 2014 According to a new technical market research report Circulating Tumor Cell (CTC) Diagnostics:...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.